166 related articles for article (PubMed ID: 36900742)
21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
22. [Multiple primary malignancies].
Bisof V; Basić-Koretić M; Juretić A; Krpan AM; Samardić KR; Rakusić Z; Santek F; Krajina Z; Podolski P; Sarić N; Crnjević TB
Lijec Vjesn; 2011; 133(11-12):384-8. PubMed ID: 22329294
[TBL] [Abstract][Full Text] [Related]
23. Metachronous occurrence of triple malignancies of kidneys, prostate, and breast. A case report and review of the literature.
Zargar-Shoshtari MA; Saffari H; Moslemi MK
Case Rep Urol; 2013; 2013():194620. PubMed ID: 23533925
[TBL] [Abstract][Full Text] [Related]
24. The results of modern surgical therapy for multiple primary lung cancers.
Adebonojo SA; Moritz DM; Danby CA
Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
[TBL] [Abstract][Full Text] [Related]
25. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
Kamp K; Damhuis RA; Feelders RA; de Herder WW
Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
[TBL] [Abstract][Full Text] [Related]
27. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
28. Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center.
Tasca G; Dieci MV; Baretta Z; Faggioni G; Montagna M; Nicoletto MO; Peccatori FA; Guarneri V; Colombo N
Front Oncol; 2020; 10():608783. PubMed ID: 33381461
[TBL] [Abstract][Full Text] [Related]
29. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
30. Synchronous gastrointestinal cancer and gastrointestinal stromal tumors: a single-institution experience.
Du J; Shen N; He HS; Fu XL; Wang JZ; Mao CZ
World J Surg Oncol; 2016 Apr; 14():130. PubMed ID: 27129592
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
[TBL] [Abstract][Full Text] [Related]
32. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study.
Panosetti E; Luboinski B; Mamelle G; Richard JM
Laryngoscope; 1989 Dec; 99(12):1267-73. PubMed ID: 2601541
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and survival of patients with multiple primary malignancies.
Wang XK; Zhou MH
World J Clin Cases; 2021 Dec; 9(34):10484-10493. PubMed ID: 35004980
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients.
Jiang Y; Miao Z; Wang J; Chen J; Lv Y; Xing D; Wang X; Wang Y; Cao Z; Zhao Z
Tumori; 2019 Dec; 105(6):474-482. PubMed ID: 30945608
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
36. Receptor characteristics of the second tumor in synchronous versus metachronous breast cancer.
Bu-Ali H; Solh M; Kapur A; Mittal V
Am Surg; 2008 Aug; 74(8):702-5; discussion 706. PubMed ID: 18705570
[TBL] [Abstract][Full Text] [Related]
37. Multiple primary malignancies--a retrospective analysis at a single center in Turkey.
Arpaci E; Tokluoglu S; Yetigyigit T; Alkis N
Asian Pac J Cancer Prev; 2013; 14(2):769-73. PubMed ID: 23621235
[TBL] [Abstract][Full Text] [Related]
38. Synchronous occurrence of gastrointestinal stromal tumors and other digestive tract malignancies in the elderly.
Shen C; Chen H; Yin Y; Chen J; Han L; Zhang B; Chen Z; Chen J
Oncotarget; 2015 Apr; 6(10):8397-406. PubMed ID: 25826075
[TBL] [Abstract][Full Text] [Related]
39. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
[TBL] [Abstract][Full Text] [Related]
40. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
